查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1959268

全球心臟幫浦設備市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Heart Pump Device Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 213 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計心臟輔助設備市場將從 2025 年的 47.4 億美元成長到 2034 年的 112.1 億美元，2026 年至 2034 年的複合年成長率為 10.03%。

受心血管疾病發病率上升和對先進心臟衰竭治療方法需求不斷成長的推動，心臟泵裝置市場預計將顯著成長。心臟幫浦裝置，包括心室輔助裝置（VAD）和人工心臟，對於需要機械輔助以維持充足血液循環的嚴重心臟病患者至關重要。隨著人們對心臟病的認知不斷提高，以及對有效治療方法的需求日益成長，對心臟泵裝置的需求也將隨之增加，預計該市場將穩步擴張。

此外，心臟泵技術的進步正在推動市場創新。更小巧、更有效率、更俱生物相容性的設備的研發，正在提升心臟泵的性能和實用性。這些創新不僅改善了患者的治療效果，還有助於降低設備植入和長期使用相關的風險。隨著對心臟泵設備新材料、新設計和新應用領域的研究不斷深入，在改善患者照護和生活品質的推動下，市場預計將進一步擴張。

此外，對個人化醫療和以患者為中心的治療方案的日益重視正在改變心臟泵設備的模式。隨著醫療服務提供者越來越認知到根據每位患者的個別需求量身定做治療方案的重要性，能夠適應不同程度心臟衰竭和患者特徵的心臟泵設備的需求預計將會增加。這一趨勢在臨床試驗和新型治療方法的研發中尤其重要，因為個人化治療方案可以改善治療效果。隨著心臟泵設備市場的不斷發展，技術進步、對個人化醫療的關注以及對有效心血管解決方案的需求將共同發揮關鍵作用，塑造其未來的發展軌跡。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心臟幫浦設備市場：依產品類型分類

  • 市場分析、洞察與預測
  • 種植類型
  • 體外安裝類型

第5章：全球心臟幫浦裝置市場：依治療方法分類

  • 市場分析、洞察與預測
  • 等待移植
  • 不適合移植患者的永久性治療
  • 手術後等待身體恢復期間的臨時支撐。
  • 治療計畫待定

第6章 全球心臟幫浦設備市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心
  • 專科診所

第7章 全球心臟幫浦設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Medtronic Plc
    • Abiomed Inc
    • Boston Scientific Corporation
    • Getinge AB
    • Terumo Corporation
    • LivaNova PLC
    • SynCardia Systems LLC
    • Jarvik Heart Inc
    • Fresenius Medical Care AG & Co. KGaA
    • Berlin Heart GmbH
    • Carmat SA
    • CorWave SA
    • Evaheart Inc
    • HeartWare International Inc
簡介目錄
Product Code: VMR112114272

The Heart Pump Device Market size is expected to reach USD 11.21 Billion in 2034 from USD 4.74 Billion (2025) growing at a CAGR of 10.03% during 2026-2034.

The heart pump device market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and the rising demand for advanced heart failure treatments. Heart pump devices, including ventricular assist devices (VADs) and total artificial hearts, are essential for supporting patients with severe heart conditions who require mechanical assistance to maintain adequate blood circulation. As awareness of heart disease grows and the need for effective treatment options increases, the demand for heart pump devices is expected to rise, positioning this market for robust expansion.

Moreover, advancements in heart pump technology are propelling innovation within the market. The development of smaller, more efficient, and biocompatible devices is enhancing the performance and usability of heart pumps. These innovations not only improve patient outcomes but also reduce the risks associated with device implantation and long-term use. As research continues to explore new materials, designs, and applications for heart pump devices, the market is likely to expand further, driven by the promise of improved patient care and quality of life.

Additionally, the growing emphasis on personalized medicine and patient-centered approaches is shaping the heart pump device landscape. As healthcare providers increasingly recognize the importance of tailoring treatments to individual patient needs, the demand for heart pump devices that can accommodate varying levels of heart failure and patient characteristics is likely to increase. This trend is particularly relevant in the context of clinical trials and the development of new therapies, where personalized approaches can enhance treatment efficacy. As the heart pump device market continues to evolve, the combination of technological advancements, a focus on personalized care, and the need for effective cardiovascular solutions will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Implantable Heart Pump Devices
  • Extracorporeal Heart Pump Devices

By Therapy

  • Bridge-To-Transplant
  • Destination Therapy
  • Bridge-To-Recovery
  • Bridge-To-Candidacy

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

COMPANIES PROFILED

  • Abbott Laboratories, Medtronic plc, Abiomed Inc, Boston Scientific Corporation, Getinge AB, Terumo Corporation, LivaNova PLC, SynCardia Systems LLC, Jarvik Heart Inc, Fresenius Medical Care AG Co KGaA, Berlin Heart GmbH, Carmat SA, CorWave SA, Evaheart Inc, HeartWare International Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL HEART PUMP DEVICE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Implantable Heart Pump Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Extracorporeal Heart Pump Devices Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL HEART PUMP DEVICE MARKET: BY THERAPY 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Therapy
  • 5.2. Bridge-To-Transplant Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Destination Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Bridge-To-Recovery Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.5. Bridge-To-Candidacy Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL HEART PUMP DEVICE MARKET: BY END-USER 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL HEART PUMP DEVICE MARKET: BY REGION 2022-2034(USD MN and K Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.2.1 By Product Type
    • 7.2.2 By Therapy
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.3.1 By Product Type
    • 7.3.2 By Therapy
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.4.1 By Product Type
    • 7.4.2 By Therapy
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.5.1 By Product Type
    • 7.5.2 By Therapy
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.6.1 By Product Type
    • 7.6.2 By Therapy
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL HEART PUMP DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Medtronic Plc
    • 9.2.3 Abiomed Inc
    • 9.2.4 Boston Scientific Corporation
    • 9.2.5 Getinge AB
    • 9.2.6 Terumo Corporation
    • 9.2.7 LivaNova PLC
    • 9.2.8 SynCardia Systems LLC
    • 9.2.9 Jarvik Heart Inc
    • 9.2.10 Fresenius Medical Care AG & Co. KGaA
    • 9.2.11 Berlin Heart GmbH
    • 9.2.12 Carmat SA
    • 9.2.13 CorWave SA
    • 9.2.14 Evaheart Inc
    • 9.2.15 HeartWare International Inc